Inotuzumab ozogamicin in combination with low‐intensity chemotherapy (mini‐HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy for older patients with Philadelphia chromosome‐negative acute lymphoblastic leukemia: A propensity score analysis
Jabbour, Elias J., Sasaki, Koji, Ravandi, Farhad, Short, Nicholas J., Garcia‐Manero, Guillermo, Daver, Naval, Kadia, Tapan, Konopleva, Marina, Jain, Nitin, Cortes, Jorge, Issa, Ghayas C., Jacob, JovitLangue:
english
Journal:
Cancer
DOI:
10.1002/cncr.32139
Date:
April, 2019
Fichier:
PDF, 451 KB
english, 2019